{
    "clinical_study": {
        "@rank": "136219", 
        "arm_group": [
            {
                "arm_group_label": "Device,  dressing", 
                "arm_group_type": "Experimental", 
                "description": "Intervention: Device, Leia dressing"
            }, 
            {
                "arm_group_label": "Dressing , device", 
                "arm_group_type": "Active Comparator", 
                "description": "Intervention: Device: Hydroactive surgical dressing"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this reseach study is to determine M\u00f6lnlycke Health Care\u00b4s Leia dressing\n      performance properties is fulfilled and that the dressing is safe when used on wound types\n      such as pressure ulcer, leg ulcer, and diabetic foot ulcer."
        }, 
        "brief_title": "Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Leg Ulcer", 
            "Diabetic Foot Ulcer", 
            "Pressure Ulcer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Pressure Ulcer", 
                "Leg Ulcer", 
                "Ulcer", 
                "Foot Ulcer", 
                "Diabetic Foot"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Low to highly exuding chronic wound(wound history > 2 months) such as Leg Ulcer,\n             Pressure Ulcer Category III to IV or Diabetic Foot Ulcer\n\n          -  Male of female, 18 years and above\n\n          -  Signed Informed Consent Form\n\n        Exclusion Criteria:\n\n          -  Pregnancy or lactation\n\n          -  Wound size not suitable for the wound dressing size\n\n          -  Known allergy/hypersensitivity to any of the components in the dressing"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01966380", 
            "org_study_id": "Leia"
        }, 
        "intervention": {
            "arm_group_label": [
                "Device,  dressing", 
                "Dressing , device"
            ], 
            "intervention_name": "Leia", 
            "intervention_type": "Device", 
            "other_name": [
                "Leia consist of conducting and absorbing part.", 
                "Device: Hydroactive surgical dressing", 
                "It is a synergetic combination of a hydroactive surgical dressing"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 16, 2013", 
        "location": {
            "contact": {
                "last_name": "Dan Curiac, MD", 
                "phone": "+46313421000"
            }, 
            "facility": {
                "address": {
                    "city": "G\u00f6teborg", 
                    "country": "Sweden", 
                    "zip": "41346"
                }, 
                "name": "Sahlgrenska clinical trial center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "An Open Randomised, Prospective, Crossover, Proof of Concept (Design Validation) Clinical Investigation to Caompare the Performance and Safety of Wound Dressing(Leia) Compared to and Hydroactive Surgical Dressing on Low to Highly Exuding Wounds", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate the performance of the investigational device dressing, with the regards to leakage, maceration and pain at dressing changes. ( Time fram: 2-3 weeks) ( Designated as safety issue: No)", 
            "measure": "Number of participants with Adverse events as a Measure of safety and telerability", 
            "safety_issue": "No", 
            "time_frame": "2-3 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01966380"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Evaluate the performance of the investigational device dressing, with the regards to leakage, maceration and pain at dressing changes.", 
            "measure": "Evaluate the performance of the investigational device dressing.", 
            "safety_issue": "No", 
            "time_frame": "2-3 weeks"
        }, 
        "source": "Molnlycke Health Care AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Molnlycke Health Care AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}